Home > Income Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Revenue

    Back to Income Statement
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹13,322 Cr₹11,813 Cr₹11,583 Cr₹12,305 Cr₹10,944 Cr

What is the latest Revenue of GLENMARK PHARMACEUTICALS ?

The latest Revenue ratio of GLENMARK PHARMACEUTICALS is ₹13,322 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹13,322 Cr
Mar2025₹11,813 Cr
Mar2024₹11,583 Cr
Mar2023₹12,305 Cr
Mar2022₹10,944 Cr

How is Revenue of GLENMARK PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2026 ₹13,322 Cr
12.77
Mar2025 ₹11,813 Cr
1.98
Mar2024 ₹11,583 Cr
-5.86
Mar2023 ₹12,305 Cr
12.44
Mar2022 ₹10,944 Cr -

Compare Revenue of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹63,636.1 Cr 1.6% 3.1% 13.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹455,394.0 Cr -3% -4.1% 16.7% Stock Analytics
DIVIS LABORATORIES ₹226,312.0 Cr 0.6% 17.5% 41.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹190,678.0 Cr 1.7% -0.6% 35.5% Stock Analytics
CIPLA ₹114,392.0 Cr -2% -0.7% -4.9% Stock Analytics
DR REDDYS LABORATORIES ₹97,740.5 Cr -1.5% -3.5% -2.2% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

1.6%

3.1%

13.6%

SENSEX

-1.4%

-1%

-4.6%


You may also like the below Video Courses